Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
ByClinical Trials Arena
Bristol Myers Squibb’s Mavacamten reduces surgical procedures among HCM patients
Findings indicate nearly 80% of participants in the mavacamten study group no longer needed surgical intervention after the 16-week period.
By
Roundtable: the future of AI in clinical research
We spoke to four leaders harnessing AI in clinical trials about its challenges and their vision for AI in the…
By
Innovation Fund Denmark: attracting investment in clinical trials
Innovation Fund Denmark invests in high-risk, high-potential innovation to improve the lives of the Danish population.
By
Telling the story: art’s potential to boost trial diversity
Lifeology is harnessing the art of visual storytelling to help fight mistrust and misinformation in the age of the ‘infodemic.’
By
Trial endpoints: is it time to get selective on surrogates?
Health policy professor Dr Huseyin Naci discusses the risks of leaning too hard on surrogate endpoints in clinical research.
By
How ketamine trials are providing a blueprint for suicidal ideation research
NIMH’s Dr Elizabeth Ballard discusses how ketamine has laid the groundwork for a new paradigm of suicide research.
By
Impressive early results for Vertex’s potentially curative stem cell diabetes therapy
A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin…
By